(NASDAQ: ACOG) Alpha Cognition's forecast annual revenue growth rate of 202.84% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 56.38%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.68%.
Alpha Cognition's revenue in 2025 is $2,928,654.On average, 2 Wall Street analysts forecast ACOG's revenue for 2025 to be $221,153,160, with the lowest ACOG revenue forecast at $213,063,167, and the highest ACOG revenue forecast at $229,243,152. On average, 2 Wall Street analysts forecast ACOG's revenue for 2026 to be $552,602,553, with the lowest ACOG revenue forecast at $511,031,205, and the highest ACOG revenue forecast at $594,173,900.
In 2027, ACOG is forecast to generate $1,470,616,447 in revenue, with the lowest revenue forecast at $1,470,616,447 and the highest revenue forecast at $1,470,616,447.